🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Urs von Holzen

University of Notre Dame

ORCID: 0000-0003-3746-6237

Also affiliated with Cancer Research Institute, University of Basel, Indiana University South Bend, Goshen Health, Indiana University School of Medicine, Indiana University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt/beta‐catenin signaling”.

Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt/beta‐catenin signaling

Journal of Pineal Research(2022)10.1111/jpi.12808
N/A
0.515DataRank · unranked
30 citations

Neha Sharda, Banabihari Giri, Md Sazzad Hassan, Damandeep Singh, Agnieszka Tarasiewicz +8 more

β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-19-1037
N/A
0DataRank · unranked
13 citations

Ashok Pullikuth, Kyle C. Nelson, Anabel Flores, Yelena Karpova, Daniele Baiz +10 more

Inhibition of signaling downstream of beta‐2 adrenoceptor by propranolol in prostate cancer cells

The Prostate(2022)10.1002/pros.24455
N/A
0DataRank · unranked
8 citations

Amaal Abdulraqeb Ali, Sazzad Hassan, Zakia Shinwari, Ayodele Alaiya, Urs von Holzen +3 more

Data from β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1

(2023)10.1158/1541-7786.c.6541105
N/A
0DataRank · unranked
0 citations

Ashok Pullikuth, Kyle C. Nelson, Anabel Flores, Yelena Karpova, Daniele Baiz +10 more

Potent antitumor activity of the KRAS G12D inhibitor MRTX1133 in pancreatic cancer: Augmenting the nanoparticle-paclitaxel chemotherapy response.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e16358
N/A
0DataRank · unranked
0 citations

N Grimaldi, Sazzad Hassan, Urs von Holzen, Niranjan Awasthi, Mitchel Ramos